Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
01 2019
Historique:
received: 17 05 2018
accepted: 13 08 2018
pubmed: 29 8 2018
medline: 21 5 2019
entrez: 29 8 2018
Statut: ppublish

Résumé

The main side effect of prostate-specific membrane antigen targeting alpha therapy (PSMA TAT) is dry mouth syndrome. Inflammation of the salivary glands and consequent reduced salivary function have been reported in patients after radioiodine therapy. The beneficial effects of sialendoscopy on radiation-induced inflammation in tissue are well known. Thus sialendoscopy with dilatation, saline irrigation and steroid injections (prednisolone) was performed before and after Eleven men with metastatic castration-resistant prostate cancer (mean age 68.5 years, range 58-80 years) underwent sialendoscopy, dilatation, saline irrigation and steroid injection of both submandibular and both parotid glands before or after every cycle of In all 11 patients both parotid and both submandibular glands were affected by radiation sialadenitis and sialendoscopy was performed. The patients experienced no complications after sialendoscopy, and showed a significant improvement in HRQOL as measured using the XQ and XI. After sialendoscopy the XQ score decreased significantly from 77.7 ± 13.6 to 42.7 ± 14.8 (p = 0.003) and the XI score decreased from 44.5 ± 6.9 to 25.8 ± 12.8 (p = 0.003). Due to the limited number of patients we only report tendencies. Sialendoscopy with dilatation, saline irrigation and steroid injection had beneficial effects on salivary gland function and HRQOL in patients undergoing

Identifiants

pubmed: 30151743
doi: 10.1007/s00259-018-4135-8
pii: 10.1007/s00259-018-4135-8
doi:

Substances chimiques

Actinium-225 0
Dipeptides 0
Heterocyclic Compounds, 1-Ring 0
PSMA-617 0
Radiopharmaceuticals 0
Prednisolone 9PHQ9Y1OLM
Prostate-Specific Antigen EC 3.4.21.77
Actinium NIK1K0956U

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-147

Références

Community Dent Health. 1999 Mar;16(1):12-7
pubmed: 10697349
N Engl J Med. 2004 Oct 7;351(15):1502-12
pubmed: 15470213
EJNMMI Res. 2018 Jul 3;8(1):56
pubmed: 29971556
J Nucl Med. 2016 Dec;57(12):1858-1864
pubmed: 27516450
Nuklearmedizin. 2018 Feb;57(1):19-25
pubmed: 29536496
Nuklearmedizin. 1997 Apr;36(3):103-9
pubmed: 9162904
Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):695-704
pubmed: 11395238
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95
pubmed: 23179945
Acta Oncol. 2011 Oct;50(7):1075-82
pubmed: 21824038
Oncotarget. 2017 Jul 6;8(33):55094-55103
pubmed: 28903405
J Nucl Med. 1998 Sep;39(9):1551-4
pubmed: 9744341
J Nucl Med. 2018 May;59(5):795-802
pubmed: 29326358
Arch Otolaryngol Head Neck Surg. 2012 Jan;138(1):15-9
pubmed: 22249623
Ann Otol Rhinol Laryngol. 2017 Nov;126(11):768-773
pubmed: 28949251
Thyroid. 2015 Jul;25(7):834-8
pubmed: 25860842
J Nucl Med. 2017 Oct;58(10):1624-1631
pubmed: 28408529
J Pain Symptom Manage. 2008 Aug;36(2):141-8
pubmed: 18395402
Cochrane Database Syst Rev. 2017 Jul 31;7:CD012744
pubmed: 28759701
Br J Oral Maxillofac Surg. 2014 Sep;52(7):641-6
pubmed: 24894709
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1280-92
pubmed: 24577951
Clin Cancer Res. 2013 Sep 15;19(18):5182-91
pubmed: 23714732
J Nucl Med. 2018 May;59(5):747-748
pubmed: 29439016
J Nucl Med. 2015 Aug;56(8):1169-76
pubmed: 26089548
Eur J Oncol Nurs. 2009 Feb;13(1):49-59
pubmed: 19201649
Head Neck. 2016 Jan;38(1):51-8
pubmed: 24995941
Lancet Oncol. 2018 Jun;19(6):825-833
pubmed: 29752180
J Nucl Med. 1998 Jul;39(7):1237-42
pubmed: 9669401
Acta Otorhinolaryngol Ital. 2017 Apr;37(2):155-159
pubmed: 28516979
J Nucl Med. 2017 Jul;58(7):1017-1018
pubmed: 28408527
Semin Radiat Oncol. 2003 Jul;13(3):226-34
pubmed: 12903012
J Nucl Med. 2018 Sep;59(9):1373-1379
pubmed: 29371410
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):950-959
pubmed: 28280855
J Nucl Med. 2016 Nov;57(11):1685-1691
pubmed: 27339871
Nuklearmedizin. 2018 Aug;57(4):160-167
pubmed: 30125928
Nucl Med Mol Imaging. 2018 Feb;52(1):80-81
pubmed: 29391917

Auteurs

Hendrik Rathke (H)

Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. hendrik.rathke@med.uni-heidelberg.de.

Clemens Kratochwil (C)

Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.

Ralph Hohenberger (R)

Department of Otorhinolaryngology, Head and Neck Surgery (ORL-HNS), Heidelberg University Hospital, Heidelberg, Germany.

Frederik Lars Giesel (FL)

Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.

Frank Bruchertseifer (F)

Directorate for Nuclear Safety and Security, European Commission, Joint Research Centre, Karlsruhe, Germany.

Paul Flechsig (P)

Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.

Alfred Morgenstern (A)

Directorate for Nuclear Safety and Security, European Commission, Joint Research Centre, Karlsruhe, Germany.

Matti Hein (M)

Department of Otorhinolaryngology, Head and Neck Surgery, SLK Klinikum Am Gesundbrunnen, Heilbronn, Germany.

Peter Plinkert (P)

Department of Otorhinolaryngology, Head and Neck Surgery (ORL-HNS), Heidelberg University Hospital, Heidelberg, Germany.

Uwe Haberkorn (U)

Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Olcay Cem Bulut (OC)

Department of Otorhinolaryngology, Head and Neck Surgery (ORL-HNS), Heidelberg University Hospital, Heidelberg, Germany.
Department of Otorhinolaryngology, Head and Neck Surgery, SLK Klinikum Am Gesundbrunnen, Heilbronn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH